Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome


Eyupoglu N. D. , ERGÜNAY K., AÇIKGÖZ PINAR A., AKYÖN YILMAZ Y., Yilmaz E. , YILDIZ O. B.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.105, sa.12, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 105 Konu: 12
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1210/clinem/dgaa600
  • Dergi Adı: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Özet

Context: Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder. Emerging animal and human data point to various changes in microbiota that could be linked with the syndrome. However, the effects of therapeutic approaches on gut microbial composition in women with PCOS remain unknown.